Shopping Cart
- Remove All
Your shopping cart is currently empty
SYHA1815, an orally active RET inhibitor (IC50=0.9 nmol/L), demonstrates antitumor activity. It exhibits greater selectivity for RET over KDR (IC50=15.9 nmol/L). SYHA1815 operates by downregulating c-Myc, arresting the G1 cell cycle, and inhibiting RET-driven cell proliferation.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,630 | 6-8 weeks | |
| 50 mg | $2,210 | 6-8 weeks | |
| 100 mg | $2,730 | 6-8 weeks |
| Description | SYHA1815, an orally active RET inhibitor (IC50=0.9 nmol/L), demonstrates antitumor activity. It exhibits greater selectivity for RET over KDR (IC50=15.9 nmol/L). SYHA1815 operates by downregulating c-Myc, arresting the G1 cell cycle, and inhibiting RET-driven cell proliferation. |
| Targets&IC50 | KRD:15.9 nM, RET:0.9 nM |
| Molecular Weight | 547.98 |
| Formula | C27H26ClF4N5O |
| Cas No. | 2760195-67-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.